돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1생성일: 2026년 10월 23일

1-Isopropylpiperazine → Ethyl 4-(2,4-difluoroanilino)-7-ethoxy-6-(4-propan-2-ylpiperazin-1-yl)quinoline-3-carboxylate

https://huagongshe.com/ko/reaction/1

반응식

참여 물질

역할이름HCID투입량
반응물1-IsopropylpiperazineHCID 78013—
반응물Ethyl 6-bromo-4-[(2,4-difluorophenyl)amino]-7-ethoxyquinoline-3-carboxylateHCID 25112109—
시약Cesium carbonateHCID 10796—
촉매Binap, (A+-)-HCID 634876—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
생성물Ethyl 4-(2,4-difluoroanilino)-7-ethoxy-6-(4-propan-2-ylpiperazin-1-yl)quinoline-3-carboxylateHCID 6843910465.39%

반응 조건

온도110 °C

반응 단계

To a solution of ethyl 6-bromo-4-(2,4-difluorophenylamino)-7-ethoxyquinoline-3-carboxylate (400 mg, 0.89 mmol) and 1-(Isopropyl)piperazine (254 µl, 1.77 mmol) in dioxane was added cesium carbonate (722 mg, 2.22 mmol), tris(dibenzylideneacetone)dipalladium(0) (40.6 mg, 0.04 mmol) and rac-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (55.2 mg, 0.09 mmol). Reaction vessel in oil bath set to 110 °C. 11am After 5 hours, MS shows product (major peak 499), and SM (minor peak 453). o/n, MS shows product peak. Reaction cooled, concentrated onto silica, and purified on ISCO. 40g column, 1:1 EA:Hex, then 100% EA. 289mg yellow solid. NMR (EN00180-62-1) supports product, but some oxidised BINAP impurity (LCMS 655).

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-56b1f4bfeebc4b8ab990b9804e798aa7
출처 메모750 AstraZeneca ELN dataset